» Articles » PMID: 24116958

Lennox-Gastaut Syndrome of Unknown Cause: Phenotypic Characteristics of Patients in the Epilepsy Phenome/Genome Project

Overview
Journal Epilepsia
Specialty Neurology
Date 2013 Oct 15
PMID 24116958
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Lennox-Gastaut syndrome (LGS) is a devastating childhood-onset epilepsy syndrome. The cause is unknown in 25% of cases. Little has been described about the specific clinical or electroencephalography (EEG) features of LGS of unknown or genetic cause (LGS(u)). The Epilepsy Phenome/Genome Project (EPGP) aims to characterize LGS(u) by phenotypic analysis of patients with LGS(u) and their parents.

Methods: One hundred thirty-five patients with LGS with no known etiology and their parents were enrolled from 19 EPGP centers in the United States and Australia. Clinical data from medical records, standardized questionnaires, imaging, and EEG were collected with use of online informatics systems developed for EPGP.

Key Findings: LGS(u) in the EPGP cohort had a broad range of onset of epilepsy from 1 to 13 years, was male predominant (p < 0.0002), and was associated with normal development prior to seizure onset in 59.2% of patients. Despite the diagnosis, almost half of the adult patients with LGS(u) completed secondary school. Parents were cognitively normal. All subjects had EEG recordings with generalized epileptiform abnormalities with a spike wave frequency range of 1-5 Hz (median 2 Hz), whereas 8.1% of subjects had EEG studies with a normal posterior dominant rhythm. Almost 12% of patients evolved from West syndrome.

Significance: LGS(u) has distinctive characteristics including a broad age range of onset, male predominance, and often normal development prior to the onset of seizures. Cognitive achievements such as completion of secondary school were possible in half of adult patients. Our phenotypic description of LGS(u) coupled with future genetic studies will advance our understanding of this epilepsy syndrome.

Citing Articles

Clinical trials for Lennox-Gastaut syndrome: Challenges and priorities.

Knowles J, Warren A, Mohamed I, Stafstrom C, Koh H, Samanta D Ann Clin Transl Neurol. 2024; 11(11):2818-2835.

PMID: 39440617 PMC: 11572735. DOI: 10.1002/acn3.52211.


Clinical features and underlying etiology of children with Lennox-Gastaut syndrome.

Zhou Z, Jiao X, Gong P, Niu Y, Xu Z, Zhang G J Neurol. 2024; 271(8):5392-5401.

PMID: 39008035 DOI: 10.1007/s00415-024-12465-3.


Prospective Study of a Multimodal Convulsive Seizure Detection Wearable System on Pediatric and Adult Patients in the Epilepsy Monitoring Unit.

Onorati F, Regalia G, Caborni C, LaFrance Jr W, Blum A, Bidwell J Front Neurol. 2021; 12:724904.

PMID: 34489858 PMC: 8418082. DOI: 10.3389/fneur.2021.724904.


GABA receptor β3 subunit mutation D120N causes Lennox-Gastaut syndrome in knock-in mice.

Qu S, Catron M, Zhou C, Janve V, Shen W, Howe R Brain Commun. 2020; 2(1):fcaa028.

PMID: 32467926 PMC: 7238755. DOI: 10.1093/braincomms/fcaa028.


Infantile Spasms of Unknown Cause: Predictors of Outcome and Genotype-Phenotype Correlation.

Yuskaitis C, Ruzhnikov M, Howell K, Allen I, Kapur K, Dlugos D Pediatr Neurol. 2018; 87:48-56.

PMID: 30174244 PMC: 8188823. DOI: 10.1016/j.pediatrneurol.2018.04.012.